Company Filing History:
Years Active: 2016
Title: Richard Possemato: Innovator in Cancer Treatment
Introduction
Richard Possemato is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the inhibition of the glycine cleavage system, which has implications for tumor cell survival and proliferation.
Latest Patents
Richard Possemato holds a patent for the "Inhibition of the glycine cleavage system for treatment of cancer." This patent outlines methods for inhibiting the survival or proliferation of tumor cells by targeting the glycine cleavage system (GCS). The methods include treating subjects in need of tumor treatment by inhibiting the GCS in the tumor. Additionally, the patent describes how to identify tumor cells sensitive to GCS inhibition by determining the overexpression of serine hydroxymethyltransferase 2 (SHMT2).
Career Highlights
Richard Possemato is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work has the potential to lead to new therapeutic strategies for cancer treatment, showcasing his commitment to advancing medical science.
Collaborations
Richard has collaborated with notable colleagues, including Dohoon Kim and David Sabatini, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Richard Possemato's contributions to cancer treatment through his patented methods highlight his role as an influential inventor in the biomedical field. His work continues to pave the way for advancements in cancer therapies.